Cargando…

Application of Metabolomics in Alzheimer’s Disease

Progress toward the development of efficacious therapies for Alzheimer’s disease (AD) is halted by a lack of understanding early underlying pathological mechanisms. Systems biology encompasses several techniques including genomics, epigenomics, transcriptomics, proteomics, and metabolomics. Metabolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilkins, Jordan Maximillian, Trushina, Eugenia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770363/ https://www.ncbi.nlm.nih.gov/pubmed/29375465 http://dx.doi.org/10.3389/fneur.2017.00719

Ejemplares similares

Alzheimer's disease mechanisms in peripheral cells: Promises and challenges
por: Trushina, Eugenia
Publicado: (2019)

Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease
por: Tönnies, Eric, et al.
Publicado: (2017)

Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics
por: Trushina, Eugenia, et al.
Publicado: (2013)

Mitochondrial complex I as a therapeutic target for Alzheimer's disease
por: Trushina, Eugenia, et al.
Publicado: (2022)

Advances in Recapitulating Alzheimer’s Disease Phenotypes Using Human Induced Pluripotent Stem Cell-Based In Vitro Models
por: Hasan, Md Fayad, et al.
Publicado: (2022)

Editorial: Metabolism in Alzheimer's Disease
por: Morris, Jill K., et al.
Publicado: (2022)

Defects in Mitochondrial Dynamics and Metabolomic Signatures of Evolving Energetic Stress in Mouse Models of Familial Alzheimer's Disease
por: Trushina, Eugenia, et al.
Publicado: (2012)

Comprehensive Method for Culturing Embryonic Dorsal Root Ganglion Neurons for Seahorse Extracellular Flux XF24 Analysis
por: Lange, Miranda, et al.
Publicado: (2012)

Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer’s disease progression and heterogeneity
por: Iturria-Medina, Yasser, et al.
Publicado: (2022)

Editorial: Systemic implications of Alzheimer's disease
por: Cortes, Constanza J., et al.
Publicado: (2023)

Bioenergetic Dysfunction and Inflammation in Alzheimer’s Disease: A Possible Connection
por: Wilkins, Heather M., et al.
Publicado: (2014)

Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy
por: Ojo, Joseph O., et al.
Publicado: (2021)

The Application of Unsupervised Clustering Methods to Alzheimer’s Disease
por: Alashwal, Hany, et al.
Publicado: (2019)

Application of CRISPR/Cas9 in Alzheimer’s Disease
por: Lu, Likui, et al.
Publicado: (2021)

Cellular Reprogramming and Its Potential Application in Alzheimer’s Disease
por: Zhou, Chao, et al.
Publicado: (2022)

Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimer’s disease patients
por: Berezhnoy, Georgy, et al.
Publicado: (2023)

Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome
por: Arnold, Matthias, et al.
Publicado: (2020)

A shape shifting organelle: unusual mitochondrial phenotype determined with three-dimensional electron microscopy reconstruction
por: Trushina, Eugenia
Publicado: (2016)

MicroRNAs in Alzheimer’s Disease: Function and Potential Applications as Diagnostic Biomarkers
por: Wei, Wei, et al.
Publicado: (2020)

Polygenic Score Models for Alzheimer’s Disease: From Research to Clinical Applications
por: Zhou, Xiaopu, et al.
Publicado: (2021)

Application of Ferulic Acid for Alzheimer’s Disease: Combination of Text Mining and Experimental Validation
por: Meng, Guilin, et al.
Publicado: (2018)

The Evolution of Tau Phosphorylation and Interactions
por: Trushina, Nataliya I., et al.
Publicado: (2019)

Biological and disease hallmarks of Alzheimer’s disease defined by Alzheimer’s disease genes
por: Murakami, Shin, et al.
Publicado: (2022)

Metabolome in progression to Alzheimer's disease
por: Orešič, M, et al.
Publicado: (2011)

Editorial: Methods and applications in Alzheimer's disease and related dementias
por: Yogi, Alvaro, et al.
Publicado: (2022)

Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma
por: Bhatnagar, Shephali, et al.
Publicado: (2014)

Random Forests Based Group Importance Scores and Their Statistical Interpretation: Application for Alzheimer's Disease
por: Wehenkel, Marie, et al.
Publicado: (2018)

Matrix disequilibrium in Alzheimer’s disease and conditions that increase Alzheimer’s disease risk
por: Amontree, Matthew, et al.
Publicado: (2023)

Low-Rank Plus Sparse Decomposition of fMRI Data With Application to Alzheimer's Disease
por: Tu, Wei, et al.
Publicado: (2022)

Advances of Mechanisms-Related Metabolomics in Parkinson’s Disease
por: Zhang, Yanyan, et al.
Publicado: (2021)

Characterization of the Meal-Stimulated Incretin Response and Relationship With Structural Brain Outcomes in Aging and Alzheimer’s Disease
por: Morris, Jill K., et al.
Publicado: (2020)

Alzheimer's Disease and Anesthesia
por: Papon, Marie-Amélie, et al.
Publicado: (2011)

Biomarkers in Alzheimer’s Disease
por: Riverol, Mario, et al.
Publicado: (2011)

Rethinking Alzheimer’s Disease
por: de Mendonça, Alexandre
Publicado: (2012)

Alzheimer’s disease and the fornix
por: Oishi, Kenichi, et al.
Publicado: (2014)

Alzheimer's disease and the microbiome
por: Bhattacharjee, Surjyadipta, et al.
Publicado: (2013)

Propionate and Alzheimer’s Disease
por: Killingsworth, Jessica, et al.
Publicado: (2021)

Epigenetics in Alzheimer’s Disease
por: Gao, Xiaodie, et al.
Publicado: (2022)

White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease
por: Klosinski, Lauren P., et al.
Publicado: (2015)

Customized Application of tDCS for Clinical Rehabilitation in Alzheimer's Disease
por: Rodella, Claudia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0si4q96qam5lmohjvnj1o61c4r